SPAC merger with Emergência Participações S.A. in Mar 2023
HPX - HPX Corp.
NYSE
->
Financial Services
->
Shell Companies
Wilmington,
United States
Type: Equity
HPX price evolution
HPX
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.22 | $0.78 | $0.3 | $0.55 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $0.36 | $0.84 | $0.42 | $0.65 |
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $59.01 | $254.22 | $253.48 | $253.69 |
| Current liabilities | ||||
| Accounts payable | $0.59 | $0.68 | $0.27 | $0.56 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1.45 | $1.54 | $0.43 | $0.72 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $13.59 | $15.06 | $14.21 | $20.13 |
| Shareholders' equity | ||||
| Retained earnings | -$18.24 | -$14.23 | -$13.73 | -$19.48 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 31 Jan 2020 | |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.55 | $1.13 | ||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $0.65 | $1.39 | ||
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $253.01 | |||
| Total investments | ||||
| Total assets | $253.69 | $254.4 | ||
| Current liabilities | ||||
| Accounts payable | $0.56 | $0.13 | ||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $0.72 | $0.29 | ||
| Long term debt | ||||
| Total noncurrent liabilities | $249.11 | |||
| Total debt | ||||
| Total liabilities | $20.13 | $249.4 | ||
| Shareholders' equity | ||||
| Retained earnings | -$19.48 | -$8.68 | ||
| Other shareholder equity | -$0 | |||
| Total shareholder equity | ||||
| (in millions $) | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 | 30 Oct 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $2.44 | $1.29 | $0.44 | $0.15 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | $0.32 | $0.02 | $0.01 | $0.01 |
| Net income | ||||
| Net income | -$0.11 | $5.71 | $1.82 | $4.46 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 31 Jan 2020 | |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1.16 | $0.31 | ||
| Operating income | -$0.31 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | $0.03 | |||
| Net income | ||||
| Net income | $9.39 | -$8.68 | ||
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 | 30 Oct 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $0.7 | |||
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.23 | -$0.25 | -$0.58 | -$0.4 |
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | ||
|---|---|---|---|---|
| Net income | -$8.68 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$0.44 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$253 | |||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $254.57 | |||
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$0.58 | $1.13 | ||
News
|
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In...
Investing.com
3 Mar 2023
|
|
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's...
Investing.com
1 Mar 2023
|
|
HPX Stock Soars 200% After Shareholders Approve Proposed Merger
InvestorPlace
1 Mar 2023
|
|
What Kind Of Shareholders Own HPX Corp. (NYSE:HPX)?
Simply Wall St. via Yahoo Finance
21 Mar 2022
|
|
What You Need To Know About HPX Corp.'s (NYSE:HPX) Investor Composition
Simply Wall St. via Yahoo Finance
4 Oct 2021
|
|
What Kind Of Shareholders Hold The Majority In HPX Corp.'s (NYSE:HPX) Shares?
Simply Wall St. via Yahoo Finance
1 Apr 2021
|
|
US-listed SPACs have a new target: Latin American tech companies
TechCrunch ExtraCrunch
1 Mar 2021
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 12.13M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $11.87M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.02 |
| EPS | $0.98 |
|---|---|
| ROA | 5.79% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.25 |
| Quick ratio | N/A |